Synthesis and Molecular Docking Analysis of New Thiazo-isoindolinedione Hybrids as Potential Inhibitors of the SARS-CoV-2 Main Protease

被引：3

作者：

Shaaban, Saad ^{[1
,2
]}

Al-Karmalawy, Ahmed A. ^{[3
]}

Alhamzani, Abdulrahman G. ^{[4
]}

Abou-Krisha, Mortaga M. ^{[4
,5
]}

Al-Qudah, Mahmoud A. ^{[4
,6
]}

Yousef, Tarek A. ^{[4
,7
]}

机构：

[1] King Faisal Univ, Dept Chem, Coll Sci, Al Hasa 31982, Saudi Arabia

[2] Mansoura Univ, Dept Chem, Fac Sci, Mansoura 35516, Egypt

[3] Ahram Canadian Univ, Dept, Fac Pharm, Giza 12566, Egypt

[4] Imam Mohammad Ibn Saud Islam Univ, Dept Chem, Coll Sci, Riyadh 11623, Saudi Arabia

[5] Yarmouk Univ, Dept Chem, Fac Sci, POB 566, Irbid 21163, Jordan

[6] South Valley Univ, Dept Chem, Qena 83523, Egypt

[7] Minist Justice, Dept Toxic & Narcot Drug, Forens Med, Medicolegal Org,Mansoura Lab, Cairo, Egypt

来源：

ORIENTAL JOURNAL OF CHEMISTRY | 2023年 / 39卷 / 04期

关键词：

Condensation; COVID-19; Isoindolinedione; Thiazolidinedione; Molecular docking;

D O I：

10.13005/ojc/390412

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Herein, we report the synthesis of novel thiazo-isoindolinedione derivatives in excellent yields (up to 92%) from the reaction of thiazolidinedione and isoindoline-dione. The structures of the novel compounds were elucidated by H-1-, C-13-NMR, and MS analyses. Furthermore, molecular docking analysis was performed to study the potential inhibition of the SARS-CoV-2 main protease (M-pro) by the new thiazo-isoindolinediones. The present study revealed that the new thiazo-isoindolinediones could inhibit the Mpro and represent a promising platform for the experimental development of new antiviral drugs based on thiazo-isoindolinedione scaffolds.

引用

页码：913 / 918

页数：6

共 50 条

[1] Molecular Docking Unveils Prospective Inhibitors for the SARS-COV-2 Main Protease
Ahmad, Fawad
Ikram, Saima
Ahmad, Jamshaid
Rehman, Irshad Ur
Khattak, Saeed Ullah
Butt, Sadia
Mushtaq, Maryam
SAINS MALAYSIANA, 2021, 50 (05): : 1473 - 1484
[2] Molecular dynamics simulation of docking structures of SARS-CoV-2 main protease and HIV protease inhibitors
Cardoso, Wesley B.
Mendanha, Sebastiao A.
JOURNAL OF MOLECULAR STRUCTURE, 2021, 1225
[3] A molecular docking study of potential inhibitors and repurposed drugs against SARS-CoV-2 main protease enzyme
Ercan, Selami
Cinar, Ercan
JOURNAL OF THE INDIAN CHEMICAL SOCIETY, 2021, 98 (03)
[4] Comparative molecular investigation of the potential inhibitors against SARS-CoV-2 main protease: a molecular docking study
Khan, Md Arif
Mahmud, Shafi
Ul Alam, A. S. M. Rubayet
Rahman, Md Ekhtiar
Ahmed, Firoz
Rahmatullah, Mohammed
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (16) : 6317 - 6323
[5] Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking
Yang, Xinbo
Xing, Xianrong
Liu, Yirui
Zheng, Yuanjie
FRONTIERS IN PHARMACOLOGY, 2022, 13
[6] Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors
Li, Daoqun
Luan, Junwen
Zhang, Leiliang
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 538 : 72 - 79
[7] An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Das, Sourav
Sarmah, Sharat
Lyndem, Sona
Singha Roy, Atanu
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (09) : 3347 - 3357
[8] Identification of potential inhibitors of SARS-CoV-2 main protease from Aloe vera compounds: A molecular docking study
Mpiana, Pius T.
Ngbolua, Koto-te-Nyiwa
Tshibangu, Damien S. T.
Kilembe, Jason T.
Gbolo, Benjamin Z.
Mwanangombo, Domaine T.
Inkoto, Clement L.
Lengbiye, Emmanuel M.
Mbadiko, Clement M.
Matondo, Aristote
Bongo, Gedeon N.
Tshilanda, Dorothee D.
CHEMICAL PHYSICS LETTERS, 2020, 754
[9] Computational Docking Study of Calanolides as Potential Inhibitors of SARS-CoV-2 Main Protease
Benalia, Abdelkrim
Abdeldjebar, Hasnia
Badji, Taqiy Eddine
FRENCH-UKRAINIAN JOURNAL OF CHEMISTRY, 2022, 10 (01): : 48 - 59
[10] Design, Synthesis, Biological Evaluation and Molecular Docking Studies of New Thiazolidinone Derivatives as NNRTIs and SARS-CoV-2 Main Protease Inhibitors
Fesatidou, Maria
Petrou, Anthi
Geronikaki, Athina
CHEMISTRY & BIODIVERSITY, 2024, 21 (12)

← 1 2 3 4 5 →